- $1.31bn
- $2.92bn
- $1.51bn
- 68
- 97
- 88
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 478 | 460 | 794 | 1,114 | 1,511 |
Cost of Revenue | |||||
Gross Profit | 351 | 329 | 589 | 780 | 623 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 305 | 400 | 352 | 452 | 1,043 |
Operating Profit | 173 | 60.3 | 441 | 662 | 468 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 99 | 8.88 | 435 | 555 | 381 |
Net Income After Taxes | 99 | 8.88 | 435 | 555 | 381 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 99 | 8.88 | 435 | 555 | 386 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 67.7 | -21.6 | 404 | 524 | 355 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.812 | 0.802 | 2.91 | 3.25 | 2.04 |
Dividends per Share | |||||
Special Dividends per Share |